The ASCOT trial is supported by funding from:

Australian Partnership for Preparedness Research on Infectious Disease Emergencies (APPRISE)

BHP Foundation

Health Research Council of New Zealand

Hospital Research Foundation

Macquarie Group Foundation

Minderoo Foundation

NSW Health

Pratt Foundation

Royal Brisbane and Women’s Hospital Foundation

The Common Good (The Prince Charles Hospital Foundation)

Wesley Medical Research

Chong Kun Dang Pharmaceutical Corporation

NSW Office for Health and Medical Research

Medical Research Future Fund

The Russell and Womersley Foundation.